Your browser doesn't support javascript.
loading
Development of a prognostic model for survival time prediction in castration-resistant prostate cancer patients.
Stangl-Kremser, Judith; Mari, Andrea; Suarez-Ibarrola, Rodrigo; D'Andrea, David; Korn, Stephan M; Pones, Mario; Kramer, Gero; Karakiewicz, Pierre; Enikeev, Dimitri V; Glybochko, Petri V; Briganti, Alberto; Shariat, Shahrokh F.
Afiliación
  • Stangl-Kremser J; Department of Urology and Comprehensive Cancer Center, Medical University of Vienna, Vienna General Hospital, Vienna, Austria.
  • Mari A; Department of Urology and Comprehensive Cancer Center, Medical University of Vienna, Vienna General Hospital, Vienna, Austria; Department of Urology, University of Florence, Unit of Oncologic Minimally-Invasive Urology and Andrology, Careggi Hospital, Florence, Italy.
  • Suarez-Ibarrola R; Department of Urology and Comprehensive Cancer Center, Medical University of Vienna, Vienna General Hospital, Vienna, Austria.
  • D'Andrea D; Department of Urology and Comprehensive Cancer Center, Medical University of Vienna, Vienna General Hospital, Vienna, Austria.
  • Korn SM; Department of Urology and Comprehensive Cancer Center, Medical University of Vienna, Vienna General Hospital, Vienna, Austria.
  • Pones M; Department of Urology and Comprehensive Cancer Center, Medical University of Vienna, Vienna General Hospital, Vienna, Austria.
  • Kramer G; Department of Urology and Comprehensive Cancer Center, Medical University of Vienna, Vienna General Hospital, Vienna, Austria.
  • Karakiewicz P; Department of Surgery, University of Montreal, Montreal, Canada.
  • Enikeev DV; Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia.
  • Glybochko PV; Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia.
  • Briganti A; Department of Urology and Division of Experimental Oncology, URI, Vita-Salute San Raffaele University, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Shariat SF; Karl Landsteiner Institute of Urology and Andrology, Vienna, Austria; Department of Urology, Weill Cornell Medical College, New York, NY; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX; Institute for Urology and Reproductive Health, Sechenov University, Moscow, Ru
Urol Oncol ; 38(6): 600.e9-600.e15, 2020 06.
Article en En | MEDLINE | ID: mdl-31953003
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias de la Próstata Resistentes a la Castración / Docetaxel / Antineoplásicos Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Humans / Male / Middle aged Idioma: En Revista: Urol Oncol Asunto de la revista: NEOPLASIAS / UROLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Austria
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias de la Próstata Resistentes a la Castración / Docetaxel / Antineoplásicos Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Humans / Male / Middle aged Idioma: En Revista: Urol Oncol Asunto de la revista: NEOPLASIAS / UROLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Austria